Literature DB >> 33437221

Similarities and differences between HIV and SARS-CoV-2.

Francisco Illanes-Álvarez1, Denisse Márquez-Ruiz1, Mercedes Márquez-Coello1, Sara Cuesta-Sancho1, José Antonio Girón-González1.   

Abstract

In the last 50 years we have experienced two big pandemics, the HIV pandemic and the pandemic caused by SARS-CoV-2. Both pandemics are caused by RNA viruses and have reached us from animals. These two viruses are different in the transmission mode and in the symptoms they generate. However, they have important similarities: the fear in the population, increase in proinflammatory cytokines that generate intestinal microbiota modifications or NETosis production by polymorphonuclear neutrophils, among others. They have been implicated in the clinical, prognostic and therapeutic attitudes. © The author(s).

Entities:  

Keywords:  AIDS; COVID-19; HIV; SARS-CoV-2; pandemics

Mesh:

Substances:

Year:  2021        PMID: 33437221      PMCID: PMC7797543          DOI: 10.7150/ijms.50133

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


  60 in total

1.  Young people: force for change.

Authors: 
Journal:  SAfAIDS News       Date:  1998-12

2.  Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.

Authors:  J F Vázquez-Castellanos; S Serrano-Villar; A Latorre; A Artacho; M L Ferrús; N Madrid; A Vallejo; T Sainz; J Martínez-Botas; S Ferrando-Martínez; M Vera; F Dronda; M Leal; J Del Romero; S Moreno; V Estrada; M J Gosalbes; A Moya
Journal:  Mucosal Immunol       Date:  2014-11-19       Impact factor: 7.313

3.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

4.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

Review 5.  Coronavirus transcription: a perspective.

Authors:  S G Sawicki; D L Sawicki
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

6.  The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?

Authors:  Chiara Mozzini; Domenico Girelli
Journal:  Thromb Res       Date:  2020-04-27       Impact factor: 3.944

Review 7.  Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.

Authors:  Camilla Tincati; Daniel C Douek; Giulia Marchetti
Journal:  AIDS Res Ther       Date:  2016-04-11       Impact factor: 2.250

8.  A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Authors:  Bin Cao; Yeming Wang; Danning Wen; Wen Liu; Jingli Wang; Guohui Fan; Lianguo Ruan; Bin Song; Yanping Cai; Ming Wei; Xingwang Li; Jiaan Xia; Nanshan Chen; Jie Xiang; Ting Yu; Tao Bai; Xuelei Xie; Li Zhang; Caihong Li; Ye Yuan; Hua Chen; Huadong Li; Hanping Huang; Shengjing Tu; Fengyun Gong; Ying Liu; Yuan Wei; Chongya Dong; Fei Zhou; Xiaoying Gu; Jiuyang Xu; Zhibo Liu; Yi Zhang; Hui Li; Lianhan Shang; Ke Wang; Kunxia Li; Xia Zhou; Xuan Dong; Zhaohui Qu; Sixia Lu; Xujuan Hu; Shunan Ruan; Shanshan Luo; Jing Wu; Lu Peng; Fang Cheng; Lihong Pan; Jun Zou; Chunmin Jia; Juan Wang; Xia Liu; Shuzhen Wang; Xudong Wu; Qin Ge; Jing He; Haiyan Zhan; Fang Qiu; Li Guo; Chaolin Huang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Dingyu Zhang; Chen Wang
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

9.  A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.

Authors:  Yong-Zhen Zhang; Edward C Holmes
Journal:  Cell       Date:  2020-03-26       Impact factor: 41.582

Review 10.  Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.

Authors:  Fei Yu; Lanying Du; David M Ojcius; Chungen Pan; Shibo Jiang
Journal:  Microbes Infect       Date:  2020-02-01       Impact factor: 2.700

View more
  5 in total

Review 1.  Immune Responses to SARS-CoV-2 in Pregnancy: Implications for the Health of the Next Generation.

Authors:  Lydia L Shook; Lindsay T Fourman; Andrea G Edlow
Journal:  J Immunol       Date:  2022-10-15       Impact factor: 5.426

2.  Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease.

Authors:  Amgad M Rabie
Journal:  ACS Omega       Date:  2022-06-13

3.  IGA nephropathy and spinal epidural abscess after COVID-19 infection: a case report.

Authors:  Burak Göre; Ezgi Coşkun Yenigün; Şimal Köksal Cevher; Emre Çankaya; Numan Aydın; Fatih Dede
Journal:  Future Virol       Date:  2022-06-28       Impact factor: 3.015

Review 4.  Combination therapies for COVID-19: An overview of the clinical trials landscape.

Authors:  Sola Akinbolade; Diarmuid Coughlan; Ross Fairbairn; Glenn McConkey; Helen Powell; Dapo Ogunbayo; Dawn Craig
Journal:  Br J Clin Pharmacol       Date:  2021-10-17       Impact factor: 3.716

Review 5.  HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae.

Authors:  Pascal Büttiker; George B Stefano; Simon Weissenberger; Radek Ptacek; Martin Anders; Jiri Raboch; Richard M Kream
Journal:  Neuropsychiatr Dis Treat       Date:  2022-10-05       Impact factor: 2.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.